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Dear Editor,
Chronic disseminated candidiasis (CDC) is a critical form of
invasive fungal infection (IFI) that affects mainly the liver,
spleen, and, occasionally, kidneys [1]. Typical clinical, micro-
biological, and/or radiological manifestations have late onset,
leading frequently to misdiagnosis [1, 2]. A late diagnosis
leads to a delay in starting an effective antifungal therapy
against Candida infection resulting in a severe morbidity
and high mortality [3]. Recent studies have shown effective
alternatives to traditional microbiological and radiological
procedures for the diagnosis of CDC, in particular, 1,3-β-D-
glucan (BDG) antigenemia and contrast-enhanced computed
tomography (CE-CT) [4, 5]. The preemptive approach, based
on the routine surveillance with serum BDG and
hepatosplenic CE-CT, has been proposed for obtaining a reli-
able and early diagnosis of CDC, and for establishing a proper
antifungal treatment [6]. However, guidelines give moderate
evidence to support recommendation for the use of such ap-
proach in clinical practice [7]. In our institution, patients with
acute leukemia at high-risk for CDC underwent diagnostic-
driven approach, which was based on the identification of the
clinical settings requiring intensive diagnostic efforts.
Between January 2013 and December 2014, 20 of 24 consec-
utive patients older than 18 years with several risk factors for
Candida infection (and on fluconazole prophylaxis), who
underwent intensive chemotherapy or autologous stem cell
transplantation (SCT), developed febrile neutropenia (FN).
In the event of FN, a standard diagnostic work-up (SDWU)
was performed as already reported [8]. Patients with persisting
fever after 4–6 days of broad-spectrum antibiotics or patients
with fever relapsing after 48 h of defervescence underwent a
baseline diagnostic work-up (BDWU) including serum BDG
antigenemia (Fungitell, manufacturer; Associated of Cape
Cod, Inc., East Falmouth, MA). An intensive diagnostic
work-up (IDWU) was performed in patients with a positive
BDG test (≥ 80 pg/mL). It includedmultiphasic CE helical CT
of the liver and spleen, as already described [9]. Among this
series of 24 patients, we report a patient suffering from CDC,
which was definitively proven by ultrasonography (US)-guid-
ed core needle cutting biopsy (CNCB) of the liver. The most
important aspect, revealed by the clinical case herein de-
scribed, is the crucial role of the serum BDG test and the
hepatosplenic multiphasic CE helical CT for the early diagno-
sis of deep-seated Candida infection.
Clinical caseA 26-year-old patient underwent autologous SCT
for acute myeloid leukemia relapsed after first-line antineo-
plastic therapy. On day 13 after chemotherapy, he developed
FN in spite of prophylaxis with fluconazole and levofloxacin.
Empiric antibiotic therapy was started. After 3 days, he was
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still febrile with abdominal pain and diarrhea. His liver and
renal tests were normal, and BDG serum screenings were
negative, such as blood cultures and US scans of the liver
and spleen; while neutropenia was still severe. About a week
later, fever and gastrointestinal symptoms regressed, also
thanks to the rise of neutrophils. The patient was discharged
to home. On day 29 after chemotherapy, the patient was again
accepted at hematology department for the reappearance of
fever (39 °C). He was not neutropenic, while it was document-
ed an increase in inflammatory markers; his liver tests were
normal. Blood cultures were negative such as US of the liver
and spleen, while the serum BDG test was positive (523 pg/
mL). Multiphasic CE helical CT showed homogeneous liver
parenchyma in the non-enhanced basal phase (Fig. 1a), but in
the following arterial phase, it detected millimetric (between 2
and 4 mm of diameter) hypodense nodules in the liver, char-
acterized by a marked rim-enhancement, highly suggestive of
micro-abscesses due to fungal infection (Fig. 1b). Ten days
later, it was documented an increase in transaminases (AST/
ALT, 54/84 U/L), ALP (207 U/L), and gamma-glutamyl
transpeptidase (GGT, 117 U/L). Gray-scale US showed the
presence of hepatomegaly, with finely inhomogeneous pattern
due to the presence of small hypo-echoic lesions (Fig. 1c). At
platelet count recovery, US-guided CNCB of the liver was
performed. Histological and microbiological assessments on
biopsy specimen documented Candida albicans infection. In
the meantime, the patient began antifungal treatment with li-
posomal amphotericin B (L-AmB) at a dose of 5 mg/kg daily,
obtaining resolution of fever and complete normalization of
serum BDG (Fig. 1d). After a total of 36 days of antifungal
therapy, CE-CT scans showed the almost complete disappear-
ance of liver lesions previously reported. At the present, he is
alive and in complete hematological remission.
Diagnostic strategy in patients at high-risk for invasive
Candida infection is still controversial [6, 7]. To improve di-
agnosis quality, the 2008 European Organization for Research
and Treatment of Cancer andMycoses StudyGroup (EORTC/
MSG) requires the demonstration of fungal elements in
Fig. 1 Serum 1,3-β-D-glucan (BDG), multiphasic contrast-enhanced he-
lical computed tomography (CT) and ultrasonography (US) scans of the
liver obtained in a 26-year-old patient with acute myeloid leukemia and
chronic disseminated candidiasis (CDC). a Basal non-contrast-enhanced
phase of CT, showing no lesions in the liver. b The arterial phase of
contrast-enhanced CT, detecting multiple nodules with marked rim-
enhancement (circles). c US detail revealing inhomogeneous pattern,
due to the presence of small hypo-echoic lesions between 2 and 4 mm
of diameter. d Trends of body temperature, serum BDG, and blood cul-
tures are shown, with the timing of diagnostic procedures and antimicro-
bial therapeutic treatments indicated by the arrows.HD L-AmB high-dose
(5 mg/kg daily) liposomal amphotericin B
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diseased tissue using invasive procedures (proven CDC) [6].
To define a CDC as probable, the imaging detection of lesions
with typical bull’s eye aspect in the liver and/or spleen is re-
quired, as well as mycological findings, in particular, an epi-
sode of candidemia in the previous 2 weeks. In spite of this re-
visitation of EORTC/MSG criteria, diagnosis of CDC is often
difficult and challenging, because the above-reported findings
may remain negative, and/or biopsy procedure for tissue char-
acterization is not always feasible [1–3]. New non-invasive
diagnostic tools against invasive Candida infection are now
available [4, 5]. Serum BDG antigenemia test in neutropenic
patients is useful for the diagnosis of CDC. A study by Tissot
et al. in patients with acute leukemia has suggested that BDG
may anticipate of a several number of days the diagnosis of
invasive candidiasis, when compared with traditional clinical,
radiological, and culture-based assessments [10]. It is reported
that BDG assay had a specificity rate for invasive Candida
infection of about 80% at a cutoff value > 80 pg/mL [4, 10]. It
is important to know that the use of albumin, gauzes, immu-
noglobulins, hemodialysis, and/or bloodstream infections due
to particular bacteria is associated with false-positive results.
When the radiological study of the liver and/or spleen is car-
ried out, a multiphasic CE-CT is considered essential [5, 7].
This technique consists in the acquisition of two different
contrast graphic sequences: a first phase prevalently arterial
and a second predominantly portal. The two phases have an
efficacy in terms of complementary overall accuracy. The
technique, for optimal results, requires a strict application,
the use of CT fast spirals equipment, preferably multilayered
because the arterial parenchyma opacification is very fast,
beginning after 15–20 s from the start of contrast injection
and it is relatively short, running out after 30–35 s, when the
portal phase starts. This kind of acquisition is crucial for the
correct visualization of the lesions. In fact, as it is possible to
see in Fig. 1a, the baseline CT examination without intrave-
nous contrast injection was not diagnostic, showing a homog-
enous liver parenchyma. In our study, among 24 consecutive
patients at high-risk for invasive Candida infection, 20 (83%)
developed FN. The diagnostic-driven antifungal approach
was able to obtain a reliable and early diagnosis of CDC in
3 of the 20 patients (one of them described above), establish-
ing a prompt and proper treatment [11]. In these three patients,
BDG was the first test appearing positive among the tests
performed for the definitive diagnosis of CDC. When BDG
result was ≥ 80 pg/mL, multiphasic CE-CT was employed
obtaining thin scans of the liver and spleen. The discovery
of the hepatosplenic nodules (with particular behavior at con-
trast medium intravenous infusion) in combination with high
serum levels of BDGmade highly suggestive the diagnosis of
CDC and allowed to promptly introduce a specific antifungal
therapy, i.e., high-dose L-AmB (5 mg/kg/die), which had led
to infection resolution and to continue chemotherapy for the
underlying hematological malignant diseases, as planned. In
all three cases with CDC, it was tested the fungal sensitivity on
core needle specimens (fluconazole-resistant candidiasis in all
of them). In our series, only one patient (4%) received empir-
ical antifungal therapy for worsening of the clinical condi-
tions, while the majority of patients received anti-yeast active
prophylaxis with fluconazole in spite of persisting FN. IDWU
with CE-CTwas required in 9/20 patients (45%) with FN. Our
strategy allowed a 77% reduction in antifungal therapy com-
pared with a standard empirical approach. At 3-month follow-
up, 95% of patients with FN survived, and no undetected IFI
were found. Although in this series, all cases of CDCwere due
to azole-resistant specimens, our current antifungal prophy-
laxis practice is based on fluconazole. In fact, 20/24 (83%)
patients at high-risk for candidiasis did not develop IFI under
fluconazole treatment. Nevertheless, we are ready to change
antifungal prophylaxis from fluconazole to echinocandin in
the presence of increased number of fluconazole-resistant
CDC cases. Finally, our series is too small to give new infor-
mation to the knowledge of CDC. Multicenter prospective
trials on clinically driven antifungal strategy with a predefined
diagnostic work-up against invasive Candida infection are
warranted.
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